ArticleFrontiers in immunology2019

Alarmin HMGB1 and Soluble RAGE as New Tools to Evaluate the Risk Stratification in Patients With the Antiphospholipid Syndrome.

Valeria Manganelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.